Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism
Authors:
Open Access
- 30 September 2013
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 275 (1) , 27-38
Abstract
Objective: Bile acid (BA) synthesis is regulated by negative feedback end‐product inhibition, initiated by farnesoid X receptors (FXRs) in liver and gut. Studies on cholic acid (CA)‐free Cyp8b1−/− mice have concluded that CA is a potent suppressor of BA synthesis. Cyp8b1−/− mice have increased BA synthesis and an enlarged BA pool, a phenotype shared with bile‐duct‐ligated, antibiotics‐administered and with germ‐free mice. Studies on such mice have concluded BA synthesis is induced due to reduced hormonal signalling by fibroblast growth factor (FGF)15 from intestine to liver. A mutual finding in these models is that potent FXR‐agonistic BAs are reduced. We hypothesized that the absence of the potent FXR agonist deoxycholic acid (DCA) may be important for the induction of BA synthesis in these situations.Design: Two of these models were investigated, antibiotic treatment and Cyp8b1−/− mice and their combination. Secondary BA formation was inhibited by ampicillin (AMP) given to wild‐type and Cyp8b1−/− mice. We then administered CA, chenodeoxycholic acid (CDCA) or DCA to AMP‐treated Cyp8b1−/− mice.Results: Our data show that the phenotype of AMP‐treated wild‐type mice resembles that of Cyp8b1−/− mice with fourfold induced Cyp7a1 expression, increased intestinal apical sodium‐dependent BA transporter expression and increased hepatic BA levels. We also show that reductions in the FXR‐agonistic BAs CDCA, CA, DCA or lithocholic acid cannot explain this phenotype; instead, it is likely due to increases in levels of α‐ and β‐muricholic BAs and ursodeoxycholic acid, three FXR‐antagonistic BAs.Conclusions: Our findings reveal a potent positive feedback mechanism for regulation of BA synthesis in mice that appears to be sufficient without endocrine effects of FGF15 on Cyp7a1. This mechanism will be fundamental in understanding BA metabolism in both mice and humans.Keywords
Funding Information
- Swedish Research Council
- Swedish Heart-Lung Foundation
- Cardiovascular Program
- Karolinska Institutet/Stockholm County Council
This publication has 35 references indexed in Scilit:
- Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese MicePLOS ONE, 2013
- Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated methodJournal of Lipid Research, 2012
- Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complexHepatology, 2012
- Effect of bile duct ligation on bile acid composition in mouse serum and liverLiver International, 2011
- Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19Journal of Internal Medicine, 2011
- Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in miceJournal of Lipid Research, 2010
- Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 ExpressionThe Journal of Pharmacology and Experimental Therapeutics, 2009
- β-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in MiceJournal of Biological Chemistry, 2003
- Catabolites of Cholesterol Synthesis Pathways and Forskolin as Activators of the Farnesoid X-Activated Nuclear ReceptorToxicology and Applied Pharmacology, 2000